Stocks
Bionano Genomics Financial Statements (BNGO) |
||||||||||
| Bionano Genomicssmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 10.03.2020 | 23.03.2021 | 01.03.2022 | 09.03.2023 | 05.03.2024 | 14.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 10.1 | 8.50 | 18.0 | 27.8 | 36.1 | 33.3 | |||
| Operating Income, bln rub | -25.9 | -38.6 | -77.1 | -131.7 | -215.2 | -108.1 | ||||
| EBITDA, bln rub | ? | -26.4 | -37.1 | -73.9 | -120.3 | -213.6 | -120.3 | |||
| Net profit, bln rub | ? | -29.8 | -41.1 | -72.4 | -132.6 | -232.5 | -135.8 | |||
| OCF, bln rub | ? | -29.5 | -38.3 | -71.9 | -124.8 | -125.2 | -84.9 | |||
| CAPEX, bln rub | ? | 0.061 | 0.000 | 1.46 | 3.30 | 1.69 | 0.848 | |||
| FCF, bln rub | ? | -29.6 | -38.3 | -73.4 | -128.1 | -126.9 | -85.7 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 29.2 | 41.3 | 81.0 | 137.6 | 149.0 | 93.2 | ||||
| Cost of production, bln rub | 6.77 | 5.73 | 14.1 | 21.9 | 26.6 | 33.7 | ||||
| R&D, bln rub | 9.08 | 10.3 | 22.5 | 49.0 | 54.0 | 33.0 | ||||
| Interest expenses, bln rub | 2.29 | 2.52 | 0.927 | 0.298 | 5.12 | 5.02 | ||||
| Assets, bln rub | 30.2 | 60.4 | 377.1 | 307.5 | 214.4 | 87.4 | ||||
| Net Assets, bln rub | ? | 3.61 | 35.1 | 337.1 | 249.4 | 96.2 | 48.9 | |||
| Debt, bln rub | 20.0 | 16.3 | 10.7 | 11.7 | 79.4 | 22.5 | ||||
| Cash, bln rub | 17.3 | 38.4 | 250.6 | 113.2 | 101.9 | 8.79 | ||||
| Net debt, bln rub | 2.71 | -22.1 | -239.9 | -101.5 | -22.5 | 13.7 | ||||
| Ordinary share price, rub | 12.4 | 30.8 | 29.9 | 14.6 | 1.89 | 1.47 | ||||
| Number of ordinary shares, mln | 1.50 | 10.4 | 27.7 | 28.9 | 34.2 | 85.9 | ||||
| Market cap, bln rub | 19 | 321 | 828 | 422 | 65 | 126 | ||||
| EV, bln rub | ? | 21 | 299 | 588 | 321 | 42 | 140 | |||
| Book value, bln rub | 4 | 26 | 254 | 131 | 62 | 38 | ||||
| EPS, rub | ? | -19.9 | -3.95 | -2.62 | -4.58 | -6.81 | -1.58 | |||
| FCF/share, rub | -19.8 | -3.68 | -2.65 | -4.43 | -3.72 | -1.00 | ||||
| BV/share, rub | 2.41 | 2.54 | 9.18 | 4.53 | 1.82 | 0.44 | ||||
| EBITDA margin, % | ? | -260.4% | -436.1% | -410.7% | -432.8% | -591.4% | -360.9% | |||
| Net margin, % | ? | -294.5% | -483.8% | -402.8% | -476.9% | -643.7% | -407.3% | |||
| FCF yield, % | ? | -159.3% | -11.9% | -8.87% | -30.3% | -196.6% | -67.9% | |||
| ROE, % | ? | -825.6% | -117.3% | -21.5% | -53.2% | -241.8% | -277.9% | |||
| ROA, % | ? | -98.8% | -68.0% | -19.2% | -43.1% | -108.4% | -155.4% | |||
| P/E | ? | -0.62 | -7.81 | -11.4 | -3.18 | -0.28 | -0.93 | |||
| P/FCF | -0.63 | -8.38 | -11.3 | -3.30 | -0.51 | -1.47 | ||||
| P/S | ? | 1.83 | 37.8 | 46.0 | 15.2 | 1.79 | 3.79 | |||
| P/BV | ? | 5.14 | 12.1 | 3.26 | 3.22 | 1.04 | 3.34 | |||
| EV/EBITDA | ? | -0.81 | -8.06 | -7.96 | -2.67 | -0.20 | -1.16 | |||
| Debt/EBITDA | -0.10 | 0.60 | 3.25 | 0.84 | 0.11 | -0.11 | ||||
| R&D/CAPEX, % | 14 873% | 1 540% | 1 485% | 3 195% | 3 895% | |||||
| CAPEX/Revenue, % | 0.60% | 0.00% | 8.12% | 11.9% | 4.68% | 2.54% | ||||
| Bionano Genomics shareholders | ||||||||||
